Australia's largest stock trading and investment forum Australia's #1 stock forum

CLH

Click for more information

0.00%

6.8¢ collection house limited

Ann: Trading Halt, page-60

First 60 Last

Share
Profile

Follow
Roops

66 Posts.

1

28/05/18

22:25

Post #: 33343499
Share

Berger -

Spoke with my advisor today and his comments were spot on.

More PDL purchases with tech and trained collection officers would make for an interesting growth story. I added more today.

Originally posted by Berger978456 ↑

But there has also been a significant increase in the efficiency of their collections team as evidenced by the below extract.

^{ The average collection rate per staff hour has increased a further 22% in fiscal year 2018, on top of the 40% improvement captured in FY17.}

So money spent on better quality PDLs and better trained collection officers can only result in an improvement in EPS and ROE.

Without putting words in Rivas mouth I'd suggest he is more about efficiency of the business at this stage as opposed to actually growing it. I think first step, get the business running super efficiently and once its running like a well oiled machine so boosting the purchases of PDLs again.

Expand

CLH Price at posting: $1.57 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 2 more messages in this thread...

First 60 Last

Add CLH (ASX) to my watchlist